Fubio (Suzhou) Biomedical Technology Co., Ltd., established in 2017, is a platform based company dedicated to the research and clinical translation of gene delivery vectors. We are committed to providing customers with one-stop virus products and services from basic research to clinical translation. The company has the most comprehensive and diverse virus vector library in China, with product pipelines covering lentivirus, adenovirus, adeno-associated virus (AAV), oncolytic virus, and other virus vectors; Up to now, we have established cooperation with more than 500 units, serving multiple fields such as life sciences, in vitro diagnostics (IVD), vaccine research and development, and cellular gene therapy (CGT), assisting scientific research and industrial clients in project research, and accelerating the transformation of clinical products.